This is a preview of subscription content, log in via an institution to check access.
REFERENCES
Colombo M, De Franchis R, Del Ninno F, Sangiovanni A, De Fazio C, Tommasini M, et al: Hepatocellular carcinoma in italian patients with cirrhosis. N Engl J Med 325:675–680, 1991
El-Refaie, Savage K, Bhattacharya S, Khakoo S, Harrison TJ, El-Batanony M, Soliman ES, Nasr S, Mokhtar N, Amer K, Scheuer PJ, Dhillon AP: HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol vol 24: 000, 1996
Grando-Lemaire V, Guettier C, Chevret S, Beaugrand M, Trinchet JC, Groupe d'étude et de traitement du carcinome hépatocellulaire: Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopatology of the non-tumorous liver. J Hepatology 3:508–513, 1999
De Mitri MS, Poussin K, Pontisso P, D'errico A, Simon N, Grigioni W, Alberti A, Beaugrand M, Pisi E, Brèchot C, Paterlini P: HCV-associated liver cancer without cirrhosis. Lancet 345:413–415, 1995
Gerber MA: Relation of hepatitis C to hepatocellular carcinoma. J Hepatol 17(suppl 3):S108–S111, 1993
Caporaso N, Romano M, Marmo R, de Sio I, Morisco F, Minerva A, Coltorti M: Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patient with cirrhosis. J Hepatol 12:367–371, 1991
Alberti A, Chemelo L, Noventa F, Morsica G, Cavalletto D, Pontisso P, Roul A: Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV. Lancet 340:697, 1992
Shindo M, Ken A, Sokawa Y, Okuno T: The virological and histological state of anti-hepatitis C virus-positive subjects withnormal liver biochemical values. Hepatology 22:418–425, 1995
Sangiovanni A, Morales R, Spinzi GC, Rumi MG, Casiraghi A, Ceriani R, Colombo E, Fossati M, Prada M, Taviani E, Minoli G: Interferon alfa treatment of HCV RNA carriers with persistently normal aminotrasferase levels: a pilot randomized controlled study. Hepatology 26:853–856, 1998
Puoti C, Magrini A, Stati T, Rigato P, Montagnese F, Rossi P, Aldegheri L, Resta S: Clinical, histologic, and virological features of hepatitis C virus carriers with persistently normal or abnormal aminotrasferase levels. Hepatology 26:1393–1398, 1997
Trevisani F, D'Intino PE, Caraceni P, Pizzo M, Stefanini GF, Mazziotti A, Grazi GL, Gozzetti G, Gasbarrini G, Bernardi M: etiologic factors and clinical presentation of hepatocellular carci noma. Dirrerences between cirrhotic and non cirrhotic Italian patients. Cancer May 75(9):2220–2232, 1995
Johnson PJ, Williams R: Cirrhosis and the etiology of hepatocellular carcinoma. J Hepatology 4:140–147, 1987
Di Bisceglie AM: Hepatitis C and hepatocellular carcinoma Semin Liver Dis. 15(1):64–69, 1995
Sakamoto D, Furukawa T, Takegami T: Hepatitis C virusnonstruttural protein NS3 trasform NHI 3T3 cells. J Virol 69:3893–3896, 1995
Ray RB, Lagging LM, Meyer K, Steele R, Ray R: Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 37:209–220, 1995
Kasahara N, Hayashi K, Mochizuki M, Takayanagi K, Yoshioka S, Kakumu A, Iijima A, Urushihara K, Kiyosowa M, Okuda K, Hino K, Okita, Osaka Liver disease Study Group: Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 27:1394–1402, 1998
Popper H, Shafritz DA, Hoofnagle JH: Relation of hepatitis B virus carrier state to hepato-cellular carcinoma. Hepatology 7:764–772, 1987
Persico M, Persico E, Suozzo R, Conte S, De seta M, Coppola L, Palmentieri B, Sasso FC, Torella R: Natural historyof hepatitis C virus carriers with persistently normal aminotrasferase levels. Gastroenterology 118:760–764, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Persico, M., Palmentieri, B., Coppola, L. et al. CASE REPORT: Occurrence of HCC in Asymptomatic HCV-Related Chronic Hepatitis. Dig Dis Sci 47, 2407–2410 (2002). https://doi.org/10.1023/A:1020527118782
Issue Date:
DOI: https://doi.org/10.1023/A:1020527118782